Target intelligence / Profile preview

Ribosomal protein L18a pseudogene 11 (RPL18AP11)

Target
RPL18AP11
Molecular classification
Other (processed pseudogene)
01

Overview

Ribosomal protein L18a pseudogene 11 (RPL18AP11, ENSG00000212695) is a processed pseudogene derived from the ribosomal protein L18a gene family in humans[2]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations, truncations, or lack of regulatory elements needed for expression. While most pseudogenes do not encode functional proteins, there is growing evidence that some transcribed pseudogenes can regulate the expression of their corresponding parent genes or related pathways by acting as competing endogenous RNAs or through other RNA-mediated mechanisms[4]. However, there is no specific evidence in the literature that RPL18AP11 is a therapeutic target, encodes an active protein, or directly participates in disease processes or drug interactions. The main biological importance of such pseudogenes is their potential involvement in gene regulation at the RNA level, though this is primarily established for a few well-studied pseudogenes and not specifically shown for RPL18AP11[2][4].

Other names
ribosomal protein 18 pseudogeneRPL18A_5_961RPL18AP11ENSG00000212695
02

Biological functions

Possible regulation of its parent protein-coding gene at the RNA level (inferred general function for processed pseudogenes)[4]
03

Disease associations

Other (no established direct disease roles; pseudogenes can sometimes regulate gene expression in cancer and other diseases, but not described for this specific pseudogene)[4]

Beyond the preview

Go deeper on Ribosomal protein L18a pseudogene 11 (RPL18AP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L18a pseudogene 11 (RPL18AP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call